Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

about

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

Item

http://www.wikidata.org/entity/Q36666666

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

@ast

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

@en

type

Item

label

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

@ast

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

@en

prefLabel

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

@ast

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

@en

P1476

Re-operative neck surgery for well-differentiated thyroid cancer of follicular origin.

@en

P2093

Jack M Monchik

http://www.w3.org/2001/XMLSchema#string

Ronald A DeLellis

http://www.w3.org/2001/XMLSchema#string

P2860

A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.

Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients.

Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy?

Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.

Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy.

Risk factor analysis in differentiated thyroid cancer.

Low-risk differentiated thyroid cancer: the need for selective treatment.

Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications.

Hayes Martin Lecture. Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer.

Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior.

P304

714-718

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.20693

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17131395

http://www.w3.org/2001/XMLSchema#string